ENDRA LIFE SCIENCES INC (NDRA)

Company Profile

ENDRA Life Sciences, Inc. develops medical imaging technology. The company is headquartered in Ann Arbor, Michigan and currently employs 21 full-time employees. The company went IPO on 2017-06-28. The firm's TAEUS technology uses radio frequency (RF) pulses to stimulate tissues, using a small fraction (less than 1%) of the amount of energy that would be transmitted into the body during an MRI scan. The use of RF energy allows its TAEUS technology to penetrate deep into tissue, enabling the imaging of human anatomy at depths equivalent to those of conventional ultrasound. The RF pulses are absorbed by tissue and converted into ultrasound signals. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease (SLD), a chronic liver disease spectrum. The company is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Company Info

ENDRA LIFE SCIENCES INC

3600 Green Ct Ste 350

Ann Arbor MICHIGAN 48105

P: 17343350468

CEO: Francois Michelon

Employees: 21

Website: https://www.endrainc.com/